We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002409:SZSEJiangsu Yoke Technology Co., Ltd. Analysis

Data as of 2026-09-05 - not real-time

CN¥126.62

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Jiangsu Yoke Technology Co., Ltd. is neutral at ¥126.62, with no clear ordering between short and long averages. The last 30 days have lost 17.8%. Relative strength is 38.1 — approaching oversold — and the MACD signal is bearish. Recent trading has carved out support near ¥125.27 and resistance around ¥163.19.
Multiples put this in overvalued territory: 58.1 times earnings against the sector's 33.2. Consensus targets land 21.8% below where the shares trade now. Revenue is growing at 16.8% on a 11.8% profit margin. The 0.48% dividend yield looks covered by current payout levels.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 84.4%, a beta of 0.48 and a maximum drawdown of 48.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.

Top Market Events

Investing3monJiangsu Yoke Technology Co LtdPrice-to-Earnings ratio, P/E Multiple, or P/E Ratio is valuation multiple...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 109.49
  • MACD momentum is negative
  • 30-day price change of -17.8%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 58.1 versus sector average of 33.2
  • Trading above the 200-day average of 109.49
  • Analyst targets imply -21.8% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 58.1 versus sector average of 33.2
  • Analyst targets imply -21.8% versus the current price
  • Revenue growth of +16.8%

Key Metrics & Analysis

Financial Health

Revenue Growth16.80%
Profit Margin11.76%
P/E Ratio58.1
ROE10.39%
ROA4.77%
Debt/Equity33.21
P/B Ratio7.5
Op. Cash FlowCN¥996.2M
Free Cash FlowCN¥527.2M
Industry P/E33.2

Technical Analysis

TrendNeutral
RSI38.1
SupportCN¥125.27
ResistanceCN¥163.19
MA 20CN¥143.19
MA 50CN¥158.83
MA 200CN¥109.49
MACDBearish
VolumeDecreasing
Fear & Greed Index95.48

Valuation

Fair ValueCN¥25.76
Target PriceCN¥99.00
Upside/Downside-21.81%
GradeOvervalued
TypeGrowth
Dividend Yield0.48%

Risk Assessment

Beta0.48
Volatility84.40%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.